Intra-individual comparison of F-FDOPA and Ga-DOTATOC PET/CT detection rate for metastatic assessment in patients with ileal neuroendocrine tumours.

Fiche publication

Date publication

août 2020

Journal

Clinical endocrinology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe , Pr KARCHER Gilles , Pr IMPERIALE Alessio

Tous les auteurs :
Ouvrard E, Chevalier E, Addeo P, Sahakian N, Detour J, Goichot B, Bachellier P, Karcher G, Taïeb D, Imperiale A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32790887

Résumé

In patients with ileal neuroendocrine tumours (ileal-NETs), head-to-head evaluation of diagnostic performances of Ga-DOTA-peptides and F-fluorodihydroxyphenylalanine ( F-FDOPA) positron emission tomography/computed tomography (PET/CT) has been performed in only few small patients' cohorts. The aim of this retrospective study was to compare Ga-DOTATOC and F-FDOPA PET/CT for metastatic disease assessment in a homogeneous large series of patients with well-differentiated ileal-NETs.